HOME > TOP STORIES

TOP STORIES

REGULATORY MHLW Proposes New Fee for Medical Management of Treatment-Resistant Schizophrenia

January 16, 2012
ORGANIZATION JGA President Sawai Says Members United to Provide Stable Drug Supplies to Meet Boosted Demand

January 13, 2012
ORGANIZATION JPWA President Bessho Expresses Resolve for Distribution Improvement

January 12, 2012
BUSINESS Kyowa Hakko Kirin to Develop Expert MRs to Boost Cancer Field

January 11, 2012
BUSINESS Bayer Yakuhin President Guth Says Marketing Success of 2 Strategic Products Key Focus

January 10, 2012
BUSINESS AZ to Utilize E-detailing, Optimize According to Product

January 6, 2012
ORGANIZATION FPMAJ Chairman Pledges Further Efforts for Permanent Introduction of Premium, Caution Towards Additional Price Cuts Becoming Rule

January 5, 2012
ORGANIZATION New Year’s Message: On behalf of the JPMA, I would like to express our best wishes for a Happy New Year as we see the start of 2012.

January 5, 2012
BUSINESS Aricept Overtakes Blopress to Take Top Spot in Domestic Drug Sales

December 28, 2011
REGULATORY Additional NHI Price Cuts Decided: ¥22.5 Billion for Long-Listed Drugs, ¥2.5 Billion for Generics

December 27, 2011
REGULATORY PFSB Draft Budget Includes ¥2.1 Bil. to Improve Review, Safety Measures

December 27, 2011
BUSINESS Chugai to Participate in Multinational Study of Avastin in Breast Cancer

December 27, 2011
REGULATORY Tougher Restrictions on Reimbursement of Vitamins to Cut ¥15 Bil. from Med. Expenditure

December 26, 2011
REGULATORY ¥25 Bil. to Be Saved through Add’l NHI Price Cuts for Both Long-listed, Generic Drugs in FY2012: MHLW

December 26, 2011
REGULATORY 0.9% Additional Price Cut for Long-Listed Drugs, Compensating Upward Revision of Nursing Fee: Minister Negotiation

December 22, 2011
BUSINESS Ranbaxy Settles with US FDA, Commits to Improvements in GMP Compliance, Data Integrity: Daiichi Sankyo

December 22, 2011
REGULATORY CSIMC Approves Additional Price Reduction for Long-listed Drugs Next Year

December 22, 2011
REGULATORY Price Cut Negotiations for Long-Listed Products Between MOF, Health Ministers “Parallel”

December 21, 2011
BUSINESS MTPC, Novartis Pharma Focused on Promoting Proper Use of MS Treatment Imusera/Gilenya

December 21, 2011
BUSINESS Chugai to Establish Pool System of Candidate Leaders

December 20, 2011

ページ

Chuikyo Debate on FY2026 Drug Pricing Reform

Chuikyo OKs New CEA Handling, with Third-Party Verification Ahead

Japan’s cost-effectiveness assessment (CEA) panel has approved a revised handling policy for the CEA system for FY2026, with the health…

COMMENTARY

Japan’s Biological Raw Material Rules Enter Major Revision; Clarity on Benefits and Safety Holds Key

By Sakura Kono

Japan is poised to make the most sweeping revision in eight years to the Standards for Biological Raw Materials —…

COLUMN

AI in Healthcare Hiring: Leveling the Playing Field & Unlocking Human Potential

By Philip Carrigan

The Japanese healthcare sector is experiencing rapid growth, demanding a highly skilled and diverse workforce. However, finding and attracting the best talent in this competitive market presents significant challenges.Enter AI. With the rise of AI-powered tools, healthcare organizations can revolutionize…